← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-7 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
CGTBiologicTakara Bio Inc.Phase 1

TS-1 (TS-1)

Pancreatic Cancer Stage III; Pancreatic Cancer Stage IV · Pancreatic Cancer Stage III

#PancreaticCancerStageIII#CGT#Phase1#인기#세포유전치료+5
효능 ORR 72.2%임상시험 55상태 RECRUITING
CGTBiologicstaleCarbiogene Therapeutics Co. Ltd.Phase 1

anti-BCMA CAR-T (anti-BCMA CAR-T)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#인기#세포유전치료+5
효능 ORR 97.1%임상시험 55상태 ACTIVE
ADCBiologicstaleEric Thompson, M.D.DM1 and Metronomic Temozolo…Phase 1

21-day TMZ (21-day TMZ)

Glioblastoma; Glioblastoma Multiforme · Glioblastoma

#Glioblastoma#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 14%임상시험 54상태 DISCONTINUED
AntibodystaleTracon Pharmaceuticals Inc.Phase 2

Androgen receptor inhibitor (Androgen receptor inhibitor)

Prostate Cancer · Prostate Cancer

#ProstateCancer#Antibody#Phase2#인기#항체+4
임상시험 54상태 RECRUITING
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

CD19/CD22 CAR T-Cells (CD19/CD22 CAR T-Cells)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#인기#세포유전치료+5
임상시험 54상태 RECRUITING
CGTBiologicstaleShenzhen Hornetcorn Bio-technol…Preclinical

CIK cell therapy (CIK cell therapy)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#CGT#Preclinical#인기#세포유전치료+4
임상시험 54상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 2

Cediranib (Cediranib)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 26%임상시험 54상태 RECRUITING
ADCBiologicstalePfizerPhase 3

Docetaxel monotherapy (Docetaxel monotherapy)

Non-small Cell Carcinoma; Non-Small Cell Lung Cancer Metastatic · Non-small Cell Carcinoma

#Non-smallCellCarcinoma#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 95%임상시험 54상태 RECRUITING
AntibodystalePfizerApproved

Elranatamab (Elranatamab)

Multiple Myeloma · FRα

#FR#Antibody#Approved#인기#항체+5
효능 ORR 61%임상시험 54상태 RECRUITING
AntibodystaleGSKvedotin) against targets ex…Approved

Mepolizumab (Mepolizumab)

Chronic Rhinosinusitis With Nasal Polyps; Asthma; Eosinophilic · Asthma

#Asthma#Antibody#Approved#인기#항체+5
효능 ORR 90.3%임상시험 54상태 ACTIVE
ADCBiologicstaleFondazione per la Medicina Pers…calicheamicin-based antibod…Phase 2

Ponatinib (Ponatinib)

Breast Cancer; Gastrointestinal Cancer · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 7.1%임상시험 54상태 ACTIVE
CGTBiologicInternational Brain Research Fo…Phase 2

Quercetin (Quercetin)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
임상시험 54상태 RECRUITING
ADCBiologicstaleSeagen Inc.deruxtecan and tucatinibPhase 1

ONT-380 (Tucatinib, Tucatinib (ONT-380))

HER2 Positive Breast Cancers · HER2

#HER2#ADC#Phase1#인기#항체약물접합체+5
효능 ORR 100%임상시험 54상태 ACTIVE
AntibodyJiangsu Hansoh Pharmaceutical C…vedotin (RC48) in combinati…Phase 2

adebrelimab and chemotherapy (adebrelimab and chemotherapy)

Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer · Efficacy and Safety of Neoadjuvant Immun

#EfficacyandSafetyofNeoadjuvantIm#Antibody#Phase2#인기#항체+5
임상시험 54상태 RECRUITING
CGTBiologicstaleNovartis PharmaceuticalsPhase 2

cytogenetic analysis (cytogenetic analysis)

Chronic Myeloproliferative Disorders; Leukemia · Colorectal Cancer

#ColorectalCancer#CGT#Phase2#인기#세포유전치료+5
임상시험 54상태 ACTIVE
CGTBiologicJohnson & Johnson Pharmaceutica…Approved

intralipid (intralipid)

Pregnancy Complicated by Low Implantation · Pregnancy Complicated by Low Implantatio

#PregnancyComplicatedbyLowImplant#CGT#Approved#인기#세포유전치료+4
임상시험 54상태 DISCONTINUED
CGTBiologicOno Pharmaceutical Co., Ltd.Phase 3

tegafur-gimeracil-oteracil potassium (tegafur-gimeracil-oteracil potassium)

Gastric Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase3#인기#세포유전치료+5
임상시험 54상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

ABT-888 (ABT-888)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 74.1%임상시험 53상태 RECRUITING
AntibodystaleRocheVedotin on Brain Metastases…Phase 2

atezolizumab (Tecentriq, Atezolizumab - 28 Day Cycle)

Endometrial Cancer · Endometrial Cancer

#EndometrialCancer#Antibody#Phase2#인기#항체+5
효능 ORR 90%임상시험 53상태 RECRUITING
CGTBiologicstaleKitevedotin plus bendamustine a…Approved

axicabtagene ciloleucel (Yescarta, axi-cel)

Large B-cell Lymphoma; Lymphoma, B-Cell · FRα

#FR#CGT#Approved#인기#세포유전치료+5
효능 ORR 92%임상시험 53상태 RECRUITING

21 / 177 페이지

← 이전다음 →